BamSEC and AlphaSense Join Forces
Learn More

Abeona Therapeutics Inc.

NASDAQ: ABEO    
Share price (12/20/24): $5.70    
Market cap (12/20/24): $248 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 17 pages Offices and Agents
12/34/56
EX-3.3
from 10-K 12 pages Offices and Agents
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to Restated Certificate of Incorporation of Abeona Therapeutics Inc
12/34/56
EX-3.2
from 10-Q 12 pages Offices and Agents
12/34/56
EX-3.1
from 10-Q 49 pages Amended and Restated Certificate of Incorporation of Abeona Therapeutics Inc
12/34/56
EX-3.2
from 8-K 17 pages Abeona Therapeutics Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Redeemable Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 18 pages Abeona Therapeutics Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Redeemable Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Amendment No. 1 to the Amended and Restated Bylaws of Abeona Therapeutics Inc
12/34/56
EX-3.1
from 8-K 17 pages Offices and Agents
12/34/56
EX-3.1
from 10-Q 16 pages Offices and Agents
12/34/56
EX-3.1
from 10-Q 7 pages Restated Certificate of Incorporation of Abeona Therapeutics Inc
12/34/56
EX-3.2
from 10-K 16 pages Offices and Agents
12/34/56
EX-3.1
from 8-K 3 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K 2 pages Article XI Exclusive Jurisdiction for Certain Actions
12/34/56
EX-3.1
from 8-K 1 page Amendment to Bylaws of Plasmatech Biopharmaceuticals, Inc
12/34/56
EX-3.15
from 8-K 4 pages Access Pharmaceuticals, Inc. Certificate of Amendment to Certificate of Designations, Rights and Preferences of Series a Cumulative Convertible Preferred Stock Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.14
from 8-K 2 pages Certificate of Amendment of Certificate of Incorporation of Access Pharmaceuticals, Inc
12/34/56
EX-3.13
from 10-Q 1 page Certificate of Amendment of Certificate of Incorporation of Access Pharmaceuticals, Inc
12/34/56
EX-3
from 10-K 1 page Certification Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
12/34/56
EX-3.11
from 10-Q 3 pages Access Pharmaceuticals, Inc. Certificate of Amendment to Certificate of Designations, Rights and Preferences of Series a Cumulative Convertible Preferred Stock Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56